CEO: Derek A. Small

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.


Key numbers

Market Capitalization:377160560
Shares Outstanding: 26047000
Float: 22658155.064999998
Next Earning Date:2020-02-27
TTm EPS: -3.7634
TTm Dividend Rate:
200 days moving average:15.47
50 days moving average: 12.63
One day percent Change: 6.31



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,